MNKD
MannKind Corporation
3.75
USD
This page is just a preview of the data found in TrendSpider’s full version
MannKind Corporation stock is down -5.3% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 19 December’s closed higher than November. In the last 6 Unusual Options Trades, there were 5 CALLs, 1 PUT.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 18 Oct 13:34 | 17 Jan, 2025 | 5.00 | 1842 | ||
| 18 Oct 13:38 | 17 Jan, 2025 | 5.00 | 1842 | ||
| 18 Oct 13:38 | 17 Jan, 2025 | 5.00 | 1842 | ||
| 18 Oct 13:42 | 17 Jan, 2025 | 5.00 | 1842 | ||
| 18 Oct 14:31 | 17 Jan, 2025 | 5.00 | 1842 | ||
| 18 Oct 19:31 | 17 Jan, 2025 | 5.00 | 51 |
MannKind focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism.
